A landmark act that allows Alaska Native, Native American, and Native Hawaiian tribes self-determination over health matters ...
Jaime Pressly's Liston James Productions has snapped up R&R for development after its proof-of-concept debut at SXSW ...
Zacks Investment Research on MSN
Can Bristol Myers Squibb's Restructuring Program Boost Earnings Growth?
Bristol Myers (BMY) is looking to boost its bottom-line growth as generic competition for legacy drugs (Revlimid, Pomalyst, ...
Here’s a look at what retailers like Freshies, Double Kwik, Weigel's and more are doing to be more efficient with fewer ...
A decade-long journey is coming to an end for Stealth BioTherapeutics and the Barth syndrome community. Will it result in the ...
Receptor proteins, expressed on the cell surface or within the cell, bind to different signaling molecules, known as ligands, ...
Recently disclosed tests with the F-22 set a new record for the AIM-120 AMRAAM in 2024, part of the form, fit, function refresh (F3R) development effort.
Before Robert Roberson's execution last fall was stayed at the eleventh hour, he had exhausted other avenues of relief ...
The US FDA has granted breakthrough therapy designation to the novel antibody-drug conjugate (ADC) raludotatug deruxtecan ...
The enteric nervous system (ENS), the largest division of autonomic nervous system, is a tantalizing frontier in neuroscience. With the advent of single-cell transcriptomics, the ENS has been ...
Travere Therapeutics, Inc. is rated Buy with FILSPARI’s robust growth, FDA approval, and key milestones ahead. Click here to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results